Medpace shares surge in premarket on upbeat 2025 outlook, while Replimune tumbles on regulatory setback. Here's a look at some of today's top premarket movers.
In the Green
INVO Fertility Inc. (IVF) is up 80% at $4.59Medpace Holdings Inc. (MEDP) is up 45% at $448.06Iovance Biotherapeutics Inc. (IOVA) is up nearly 15% at $2.86Genprex Inc. (GNPX) is up 10% at $0.28Rapt Therapeutics Inc (RAPT) is up 7% at $12.55Liminatus Pharma Inc. (LIMN) is up over 6% at $5.94Beyond Air Inc. (XAIR) is up nearly 5% at $3.43
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.